LIN52 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.259600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.492400E-01
Normal-vs-Stage2
9.260400E-01
Normal-vs-Stage3
2.113500E-02
Normal-vs-Stage4
3.081000E-01
Stage1-vs-Stage2
2.301000E-01
Stage1-vs-Stage3
1.790370E-02
Stage1-vs-Stage4
8.957000E-01
Stage2-vs-Stage3
7.412200E-04
Stage2-vs-Stage4
2.431200E-01
Stage3-vs-Stage4
7.795000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.998400E-01
Normal-vs-AfricanAmerican
7.249600E-01
Normal-vs-Asian
4.999800E-01
Caucasian-vs-AfricanAmerican
9.211600E-01
Caucasian-vs-Asian
1.216040E-01
AfricanAmerican-vs-Asian
2.128000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.168000E-01
Normal-vs-Female
8.282200E-01
Male-vs-Female
9.126000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.854000E-01
Normal-vs-Age(41-60Yrs)
5.876800E-01
Normal-vs-Age(61-80Yrs)
9.466400E-01
Normal-vs-Age(81-100Yrs)
6.910200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.642400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.914800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.444300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.238300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.456500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.215200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.322600E-01
Normal-vs-Daily Drinker
7.173400E-01
Normal-vs-Weekly Drinker
9.333800E-01
Normal-vs-Occasional Drinker
8.100800E-01
Normal-vs-Social Drinker
5.472800E-01
Non Drinker-vs-Daily Drinker
9.211800E-01
Non Drinker-vs-Weekly Drinker
6.915200E-01
Non Drinker-vs-Occasional Drinker
3.029000E-01
Non Drinker-vs-Social Drinker
1.171800E-01
Daily Drinker-vs-Weekly Drinker
6.655400E-01
Daily Drinker-vs-Occasional Drinker
2.746400E-01
Daily Drinker-vs-Social Drinker
1.135570E-01
Weekly Drinker-vs-Occasional Drinker
5.734200E-01
Weekly Drinker-vs-Social Drinker
1.900990E-01
Occasional Drinker-vs-Social Drinker
3.485600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.634400E-01
Normal-vs-Grade 2
2.308000E-01
Normal-vs-Grade 3
2.385800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.698800E-01
Grade 1-vs-Grade 3
4.537800E-01
Grade 1-vs-Grade 4
4.634400E-01
Grade 2-vs-Grade 3
6.613800E-01
Grade 2-vs-Grade 4
2.308000E-01
Grade 3-vs-Grade 4
2.385800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.773600E-01
Normal-vs-NonDiabetic
8.881400E-01
Diabetic-vs-NonDiabetic
5.272600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.382000E-01
Normal-vs-NoPancreatitis
8.517400E-01
Pancreatitis-vs-NoPancreatitis
3.240600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.087800E-01
Normal-vs-N1
9.285800E-01
N0-vs-N1
2.136600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.747000E-01
Normal-vs-TP53-NonMutant
5.117200E-01
TP53-Mutant-vs-TP53-NonMutant
5.471500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
